Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 23, Issue 17, Pages 5979-5988Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.17.5979-5988.2003
Keywords
-
Categories
Funding
- NIGMS NIH HHS [T32 GM008715, T32 GM08715] Funding Source: Medline
Ask authors/readers for more resources
Estrogen receptor alpha (ERalpha) degradation is regulated by ubiquitination, but the signaling pathways that modulate ERalpha turnover are unknown. We found that extracellular signal-regulated kinase 7 (ERK7) preferentially enhances the destruction of ERalpha but not the related androgen receptor. Loss of ERK7 was correlated with breast cancer progression, and all ERalpha-positive breast tumors had decreased ERK7 expression compared to that found in normal breast tissue. In human breast cells, a dominant-negative ERK7 mutant decreased the rate of endogenous ERalpha degradation >4-fold in the presence of hormone and potentiated estrogen responsiveness. ERK7 targets the ERalpha ligand-binding domain for destruction by enhancing its ubiquitination. Thus, ERK7 is a novel regulator of estrogen responsiveness through its control of ERalpha turnover.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available